IREN Stock Price Prediction: Analyst cuts meet a bearish technical reset

What changed and why the stock is under pressure

IREN shares are trying to digest a sharp reset in expectations after the company’s fiscal first-quarter 2027 update and a fresh wave of analyst revisions. On November 10, Investing.com reported the stock fell 3.3% intraday to $20.71 as CCB Int’l downgraded IREN from outperform to neutral and set a $40 target. That followed the earlier disappointment around IREN’s Q1 FY27 report, where AI Cloud revenue nearly tripled sequentially to $200 million, but the company said its goal of surpassing $4 billion in annual recurring revenue had slipped from year-end 2026 to at least January 2027, and possibly February. CNBC also reported on November 5 that the delay was tied to a customer-requested change and supplier timing, with co-CEO Daniel Roberts identifying Microsoft as the customer. citeturn0search0turn0search4

Broker cuts have continued to compress the stock’s valuation backdrop. On November 9, JPMorgan cut its target to $55 from $65 while keeping an Overweight rating, citing the delay in Horizon 2-4 deliveries to end-January 2027, with possible further slippage into February. Goldman Sachs also cut its target to $30 from $50 and held a Neutral rating, pointing to fiscal first-quarter revenue of $228 million, down 5% year over year, and adjusted EBITDA of $66 million, down 28%. Cantor Fitzgerald cut its target to $47 from $99, also retaining an Overweight rating, after lowering its adjusted EBITDA estimates and target multiple. citeturn0search1turn0search2turn0search3

Price action: the chart is still saying “repair first, trend later”

The market data show a damaged near-term structure. IREN is trading at $19.96, below the 7-day SMA at $20.98, the 20-day SMA at $23.17, and the 50-day SMA at $30.84. That alignment is bearish: short-term trend below intermediate trend below longer-term trend. The stock is also below the 12-day EMA at $21.71 and the 26-day EMA at $24.58, which reinforces that rallies are still happening under declining trend pressure. citeturn0search5

Momentum is weak but not fully washed out. The 14-day RSI is 34.29, which is near the lower end of neutral rather than outright oversold. MACD is negative at -2.8753, with a zero histogram, while stochastic readings at 33.86 and 27.09 show the stock is still rebuilding from a weak posture rather than breaking out. That matches the broader setup: the stock has already corrected hard, but there is no confirmed recovery signal yet. citeturn0search5

Key levels traders are watching

The nearest reference points are clear. Immediate support sits at $19.11, with strong support at $18.25. Bollinger Bands put the lower band at $18.13 and %B at 0.1812, which means price is trading close to the lower edge of the recent volatility envelope. On the upside, pivot resistance is $20.44, immediate resistance is $21.30, and strong resistance is $22.63. citeturn0search5

That structure matters because the stock is not yet back above the first band of resistance that would suggest repair in trend. A close back over $21.30 would be the first sign that sellers are losing control of the rebound. Failure to hold $19.11 leaves $18.25 and the lower Bollinger Band as the next obvious test. citeturn0search5

Binance Futures positioning: buyers are present, but leverage is being reduced

Derivatives data are not telling the same story as the spot chart. On Binance perpetual futures, funding is slightly positive at 0.0090%, which is still close to neutral. Open interest stands at 257,909.97 contracts, with a 24-hour decline of 7.93%, indicating position closing or liquidations rather than fresh leverage building. citeturn0search6

The long/short mix leans constructive, but it should be read carefully. Binance global accounts show 68.1% long versus 31.9% short, while top-trader accounts are even more tilted at 76.4% long versus 23.6% short. Taker flow is also bid-heavy, with a 1.5183 buy/sell ratio. That suggests aggressive buying interest is present, but it does not override the fact that open interest is falling and price remains below trend. In other words: dip buyers are active, yet the market is still de-risking. citeturn0search6

The setup from here

The clean read is that IREN is in a post-earnings digestion phase, not a confirmed reversal. The fundamental issue is timing: the revenue ramp is still intact in direction, but the market is reacting to delay risk, customer-specific execution changes, and lowered broker assumptions. The technical issue is that the stock is below every major short- and medium-term average, with momentum weak and support only a little below the current print. citeturn0search0turn0search1turn0search2turn0search3turn0search5

If IREN can hold the $19.11 to $18.25 support zone and reclaim $21.30, the chart would start to shift from breakdown risk toward base-building. If support fails, the market is likely to keep pressuring the lower Bollinger Band and then the next support shelf. The next material catalyst is not date-specific beyond the broker and earnings developments already reported, so near-term timing remains tied to follow-up guidance and execution updates.